Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects

Background: Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated with an increased risk of developing cardiovascular diseases (CVD) and fibrinolyt...

Descrición completa

Detalles Bibliográficos
Main Authors: Al-Hamodi, Z., Ismail, I.S., Saif-Ali, R., Ahmed, K.A., Muniandy, S.
Formato: Artigo
Idioma:English
Publicado: 2011
Subjects:
Acceso en liña:http://eprints.um.edu.my/7212/1/Al-Hamodi-2011-Association_of_plasm.pdf